Latest Comments

Could Novartis’ longer-acting anti-VEGF Drug, RTH258, offset Lucentis’ loss to Eylea?

Could Novartis’ longer-acting anti-VEGF Drug, RTH258, offset Lucentis’ loss to Eylea?

NeuPSIG 2017: sodium channel blockers highlight a new approach to neuropathic pain

NeuPSIG 2017: sodium channel blockers highlight a new approach to neuropathic pain

NeuPSIG 2017: three strategies for improving treatment options for neuropathic pain

NeuPSIG 2017: three strategies for improving treatment options for neuropathic pain

EULAR 2017: Lupus community remains divided on outcome measures

EULAR 2017: Lupus community remains divided on outcome measures

Fecal transplant-based treatment for C. difficile reaches phase III trials

Fecal transplant-based treatment for C. difficile reaches phase III trials

EULAR 2017: Chondroitin Sulphate surprises with good results in knee osteoarthritis

EULAR 2017: Chondroitin Sulphate surprises with good results in knee osteoarthritis

Is tau the way forward to treat Alzheimer’s disease?

Is tau the way forward to treat Alzheimer’s disease?

Unpredictable epidemiology necessitates a more empirical approach to Zika and Ebola vaccine development

Unpredictable epidemiology necessitates a more empirical approach to Zika and Ebola vaccine development

A 10-Year Race: Antibody Biosimilars Versus “Other” Biosimilars

A 10-Year Race: Antibody Biosimilars Versus “Other” Biosimilars

Get Granular, Beat Cancer

Get Granular, Beat Cancer

The death of medicine

The death of medicine

Will acne be the next indication to benefit from biologics?

Will acne be the next indication to benefit from biologics?

The Three-Pronged Strategy to Combat NASH

The Three-Pronged Strategy to Combat NASH

Majority of UC Cases Considered Mild to Moderate

Majority of UC Cases Considered Mild to Moderate

New Data Released for Roche’s Latest Game-Changing Drug for Multiple Sclerosis

New Data Released for Roche’s Latest Game-Changing Drug for Multiple Sclerosis

Carcinoma Remains Predominant Histologic Subtype of Ovarian Cancer

Carcinoma Remains Predominant Histologic Subtype of Ovarian Cancer

EMA withdrawal threatens UK patient access to cutting edge therapies

EMA withdrawal threatens UK patient access to cutting edge therapies

Improved and affordable diagnostics for kidney transplant rejection

Improved and affordable diagnostics for kidney transplant rejection

Unmet needs in melanoma treatment

Unmet needs in melanoma treatment

Viability of GSK’s Mosquirix hinges on key pilot study for malaria prevention

Viability of GSK’s Mosquirix hinges on key pilot study for malaria prevention

Verily aims to become a prophet of human health

Verily aims to become a prophet of human health